Oska Pulse to Exhibit at the 16th World Congress on Endometriosis
Australian-designed device brings innovative PEMF therapy to the global spotlight
Sydney, Australia – May 2025 – Oska Pulse, a leading innovator in non-invasive pain management, is proud to announce its participation in the 16th World Congress on Endometriosis (WCE 2025), taking place from 21–24 May 2025 in Sydney.
As part of this prestigious global event, Oska will be showcasing its wearable PEMF therapy device, designed in Australia and manufactured in the USA, to help manage pain and improve the quality of life for people living with endometriosis and other women’s health conditions.
This year's congress, hosted by the World Endometriosis Society, will bring together world-leading researchers, clinicians, and allied health professionals to share the latest advancements in endometriosis care, science, and patient support.
Groundbreaking Clinical Research to be Shared at WCE 2025
Professor Sylvia Mechsner from Charité – Universitätsmedizin Berlin, one of Europe’s foremost experts in endometriosis, will present a poster talk at WCE 2025, discussing the progress of an ongoing double-blind randomised controlled trial (RCT) on the use of PEMF therapy via the Oska Pulse device.
The study, which began in December 2023, aims to evaluate the effectiveness of PEMF therapy in reducing endometriosis symptoms and improving quality of life. The study is being conducted at Charité – a globally recognised leader in clinical research. Results are expected in Summer 2025, with publication to follow shortly after.
Visit Oska Pulse at WCE 2025
Meet our team – Discover the science behind PEMF therapy and how Oska Pulse supports people living with endometriosis.
Learn from experts – Gain insight into the future of PEMF therapy through Prof Mechsner’s research.
Try the device – Experience first-hand how Oska Pulse is already helping people live with less pain.
Book a session – Schedule a meeting with our team or learn how to connect with Prof Mechsner during the congress.
Join Us in Sydney
Don't miss the chance to connect with global leaders in women's health at WCE 2025. Whether you’re a clinician, researcher, allied health professional or someone passionate about endometriosis care, we invite you to visit the Oska Pulse stand in the exhibition hall.
Learn more about WCE 2025: www.wce2025.com.au
Read more about the clinical study: https://www.oskapulse.health/clinical-studies/blog-post-title-one-97ekf-w6zhw
About Oska Pulse
Oska Pulse is a portable, non-invasive, drug-free PEMF therapy device designed to support pain management and healing. It is an FDA-cleared Class I device in the United States and a Class IIa medical device approved in Australia, the UK, and across CE-recognised regions for the treatment of pain, inflammation and arthritis.
To learn more, visit www.oskapulse.health
Press Contact: Darren Wedge
Head of International Operations & Founder
phone: + 61 414230022
email: darren@oskawellness.com